Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / Common Stock, no par value
- Total 13F shares
- 590,438
- Total 13F value
- $816,220
- Share change
- +174,555
- SEC-reported price per share
- $1.39
- Number of holders
- 28
- Value change
- +$77,206
- Number of buys
- 10
- Number of sells
- 11
- Shares outstanding
- 109,272,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
28
Top holders
10
ONCY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Ownership snapshot
Top reported holders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 0.13%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 0.13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
0.13%
ROYAL BANK OF CANADA
0.06%
SCOTIA CAPITAL INC.
0.04%
CITADEL ADVISORS LLC
0.03%
CIBC WORLD MARKET INC.
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
0.13%
|
$668,000
140,278 shares
|
— | 31 Dec 2019 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.06%
|
$286,000
60,165 shares
|
— | 31 Dec 2019 |
| SCOTIA CAPITAL INC. |
13F
Company
|
0.04%
|
$223,000
47,227 shares
|
— | 31 Dec 2019 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.03%
|
$154,000
32,465 shares
|
— | 31 Dec 2019 |
| CIBC WORLD MARKET INC. |
13F
Company
|
0.02%
|
$82,000
17,193 shares
|
— | 31 Dec 2019 |
| Federation Des Caisses Desjardins du Quebec |
13F
Individual
|
0.01%
|
$74,270
15,685 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
28
Shares
590,438
Rows available
28
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2026 Across Filers
Q1 2026 holders
57
Q1 2020 holders
28
Holder diff
-29
| Investor | Q1 2026 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend